Liver X receptor: A cardinal target for atherosclerosis and beyond

Journal of Atherosclerosis and Thrombosis

Volumn 21, Issue 6, 2014, Pages 519-531

  Parikh, Mihir ^a   Patel, Kirti ^b   Soni, Sachin ^a   Gandhi, Tejal ^a  

^a ANAND PHARMACY COLLEGE   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Atherosclerosis; Lipid; Liver X receptor; LXR; Steroid

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G5; ABC TRANSPORTER G8; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); DNA BINDING PROTEIN; FARNESOID X RECEPTOR; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; NIEMANN PICK C1 LIKE 1 PROTEIN; NUCLEAR RECEPTOR COREPRESSOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOLIPID TRANSFER PROTEIN; PROSTAGLANDIN E2; RETINOID X RECEPTOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; BILE ACID; CHOLESTEROL; ISOPROTEIN; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROID; THYROID HORMONE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BILE ACID METABOLISM; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DIABETES MELLITUS; DIETARY CHOLESTEROL ABSORPTION; DNA RESPONSIVE ELEMENT; FATTY ACID SYNTHESIS; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATORY INFILTRATE; INTESTINE ABSORPTION; LIPID HOMEOSTASIS; MALE FERTILITY; METABOLIC REGULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SPERMATOGENESIS; STEROIDOGENESIS; TRANSCRIPTION REGULATION; ADRENAL GLAND; ANIMAL; DIET; FEMALE; INFLAMMATION; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ADRENAL GLANDS; ANIMALS; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; CHOLESTEROL; DIET; FEMALE; HUMANS; INFLAMMATION; MALE; MICE; ORPHAN NUCLEAR RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROTEIN ISOFORMS; SKIN; STEROIDS; THYROID HORMONES;

EID: 84903157798     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.19778     Document Type: Review

References (106)

1. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev, 1995; 9: 1033-1045
2. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature, 1996; 383: 728-731
3. Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, Pfahl M: A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol, 1994; 14: 7025-7035
4. Desvergne B, Michalik L, Wahli W: Transcriptional regulation of metabolism. Physiol Rev, 2006; 86: 465-514
5. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P, Newgard CB, Spiegelman BM: Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell, 2005; 120: 261-273
6. Herzog B, Hallberg M, Seth A, Woods A, White R, Parker MG: The nuclear receptor cofactor, receptorinteracting protein 140, is required for the regulation of hepatic lipid and glucose metabolism by liver X receptor. Mol Endocrinol, 2007; 21: 2687-2697
7. Jakobsson T, Venteclef N, Toresson G, Damdimopoulos AE, Ehrlund A, Lou X, Sanyal S, Steffensen KR, Gustafsson JA, Treuter E: GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell, 2009; 34: 510-518
8. Kim GH, Park K, Yeom SY, Lee KJ, Kim G, Ko J, Rhee DK, Kim YH, Lee HK, Kim HW, Oh GT, Lee KU, Lee JW, Kim SW: Characterization of ASC-2 as an antiatherogenic transcriptional coactivator of liver X receptors in macrophages. Mol Endocrinol, 2009; 23: 966-974
9. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science, 2000; 289: 1524-1529
10. Wagner BL, Valledor AF, Shao G, Daige CL, Bischoff ED, Petrowski M, Jepsen K, Baek SH, Heyman RA, Rosenfeld MG, Schulman IG, Glass CK: Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol Cell Biol, 2003; 23: 5780-5789
11. Glass CK, Rosenfeld MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev, 2000; 14: 121-141
12. Teboul M, Enmark E, Li Q, Wikstrom AC, Pelto-Huikko M, Gustafsson JA: OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor. Proc Natl Acad Sci U S A, 1995; 92: 2096-2100
13. Fan X, Kim HJ, Bouton D, Warner M, Gustafsson JA: Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of laterborn neurons. Proc Natl Acad Sci U S A, 2008; 105: 13445-13450
14. Lee JH, Zhou J, Xie W: PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks. Mol Pharm, 2008; 5: 60-66
15. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, Mangelsdorf DJ: Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A, 1999; 96: 266-271
16. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem, 1997; 272: 3137-3140
17. Song C, Hiipakka RA, Liao S: Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids, 2000; 65: 423-427
18. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E: The nuclear receptor LXR is a glucose sensor. Nature, 2007; 445: 219-223
19. Edwards PA, Kennedy MA, Mak PA: LXRs; oxysterolactivated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol, 2002; 38: 249-256
20. Zelcer N, Tontonoz P: Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest, 2006; 116: 607-614
21. Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NC, Freake HC: Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev, 1987; 8: 288-308
22. Hashimoto K, Mori M: Crosstalk of thyroid hormone receptor and liver X receptor in lipid metabolism and beyond [Review]. Endocr J, 2011; 58: 921-930
23. Flamant F, Samarut J: Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab, 2003; 14: 85-90
24. Yen PM, Feng X, Flamant F, Chen Y, Walker RL, Weiss RE, Chassande O, Samarut J, Refetoff S, Meltzer PS: Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep, 2003; 4: 581-587
25. Weiss RE, Murata Y, Cua K, Hayashi Y, Seo H, Refetoff S: Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Endocrinology, 1998; 139: 4945-4952
26. Berkenstam A, Farnegardh M, Gustafsson JA: Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Mech Ageing Dev, 2004; 125: 707-717
27. Gullberg H, Rudling M, Salto C, Forrest D, Angelin B, Vennstrom B: Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol, 2002; 16: 1767-1777
28. Shin DJ, Plateroti M, Samarut J, Osborne TF: Two uniquely arranged thyroid hormone response elements in the far upstream 5' flanking region confer direct thyroid hormone regulation to the murine cholesterol 7alpha hydroxylase gene. Nucleic Acids Res, 2006; 34: 3853-3861
29. Quinet EM, Savio DA, Halpern AR, Chen L, Schuster GU, Gustafsson JA, Basso MD, Nambi P: Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Mol Pharmacol, 2006; 70: 1340-1349
30. Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE: Crosstalk between Thyroid Hormone Receptor and Liver X Receptor Regulatory Pathways Is Revealed in a Thyroid Hormone Resistance Mouse Model. J Biol Chem, 2006; 281: 295-302
31. Menke JG, Macnaul KL, Hayes NS, Baffic J, Chao YS, Elbrecht A, Kelly LJ, Lam MH, Schmidt A, Sahoo S, Wang J, Wright SD, Xin P, Zhou G, Moller DE, Sparrow CP: A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alphahydroxylase (CYP7a). Endocrinology, 2002; 143: 2548-2558
32. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A, 1997; 94: 4312-4317
33. Tobin KA, Steineger HH, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI: Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol, 2000; 14: 741-752
34. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, Tontonoz P: Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol, 2001; 21: 7558-7568
35. Yoshikawa T, Shimano H, Yahagi N, Ide T, Amemiya-Kudo M, Matsuzaka T, Nakakuki M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Takahashi A, Sone H, Osuga Ji J, Gotoda T, Ishibashi S, Yamada N: Polyunsaturated fatty acids suppress sterol regulatory elementbinding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem, 2002; 277: 1705-1711
36. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest, 1999; 103: 1489-1498
37. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, Gotoda T, Ishibashi S, Yamada N: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem, 1999; 274: 35832-35839
38. Ide T, Shimano H, Yoshikawa T, Yahagi N, Amemiya-Kudo M, Matsuzaka T, Yatoh S, Kitamine T, Okazaki H, Tamura Y, Sekiya M, Takahashi A, Hasty AH, Sato R, Sone H, Osuga J, Ishibashi S, Yamada N: Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol, 2003; 17: 1255-1267
39. Brunham LR, Kruit JK, Iqbal J, Fievet C, Timmins JM, Pape TD, Coburn BA, Bissada N, Staels B, Groen AK, Hussain MM, Parks JS, Kuipers F, Hayden MR: Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest, 2006; 116: 1052-1062
40. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH: Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A, 2002; 99: 16237-16242
41. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, Mangelsdorf DJ: Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem, 2002; 277: 18793-18800
42. Altmann SW, Davis HR, Jr., Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, Graziano MP: Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 2004; 303: 1201-1204
43. Iqbal J, Hussain MM: Intestinal lipid absorption. Am J Physiol Endocrinol Metab, 2009; 296: E1183-E1194
44. Tang W, Ma Y, Jia L, Ioannou YA, Davies JP, Yu L: Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice. Arterioscler Thromb Vasc Biol, 2008; 28: 448-454
45. Alvaro A, Rosales R, Masana L, Vallve JC: Polyunsatu-rated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem, 2010; 21: 518-525
46. Francis GA, Knopp RH, Oram JF: Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest, 1995; 96: 78-87
47. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, Tontonoz P: LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A, 2001; 98: 507-512
48. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, Tontonoz P: The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol, 2003; 23: 2182-2191
49. Luo Y, Tall AR: Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest, 2000; 105: 513-520
50. Masson D, Staels B, Gautier T, Desrumaux C, Athias A, Le Guern N, Schneider M, Zak Z, Dumont L, Deckert V, Tall A, Jiang XC, Lagrost L: Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse. J Lipid Res, 2004; 45: 543-550
51. Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ: Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem, 2001; 276: 43018-43024
52. Wang N, Lan D, Chen W, Matsuura F, Tall AR: ATPbinding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A, 2004; 101: 9774-9779
53. Schuster GU, Parini P, Wang L, Alberti S, Steffensen KR, Hansson GK, Angelin B, Gustafsson JA: Accumulation of foam cells in liver X receptor-deficient mice. Circulation, 2002; 106: 1147-1153
54. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, Billheimer JT, Rothblat GH, Rader DJ: Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation, 2006; 113: 90-97
55. Russell DW, Setchell KD: Bile acid biosynthesis. Biochemistry, 1992; 31: 4737-4749
56. Rader DJ: Liver X receptor and farnesoid X receptor as therapeutic targets. Am J Cardiol, 2007; 100: n15-9
57. Peet DJ, Turley SD, Ma W, Janowski BA, Lobaccaro JM, Hammer RE, Mangelsdorf DJ: Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell, 1998; 93: 693-704
58. Goodwin B, Watson MA, Kim H, Miao J, Kemper JK, Kliewer SA: Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol, 2003; 17: 386-394
59. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA: A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell, 2000; 6: 517-526
60. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science, 2000; 290: 1771-1775
61. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, Kuipers F: Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J Biol Chem, 2002; 277: 34182-34190
62. Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, He J, Lee JH, Khadem S, Ren S, Li S, Silverstein RL, Xie W: Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology, 2008; 134: 556-567
63. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B: Role of LXRs in control of lipogenesis. Genes Dev, 2000; 14: 2831-2838
64. Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, Matsuzaka T, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Osuga J, Harada K, Gotoda T, Kimura S, Ishibashi S, Yamada N: Identification of liver X receptorretinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol, 2001; 21: 2991-3000
65. Inaba T, Matsuda M, Shimamura M, Takei N, Terasaka N, Ando Y, Yasumo H, Koishi R, Makishima M, Shimomura I: Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem, 2003; 278: 21344-21351
66. Jakel H, Nowak M, Moitrot E, Dehondt H, Hum DW, Pennacchio LA, Fruchart-Najib J, Fruchart JC: The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J Biol Chem, 2004; 279: 45462-45469
67. Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, Anghel A, Lutfy K, Friedman TC: Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology, 2006; 147: 5061-5068
68. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, Saez E, Tontonoz P: Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A, 2003; 100: 5419-5424
69. Grefhorst A, van Dijk TH, Hammer A, van der Sluijs FH, Havinga R, Havekes LM, Romijn JA, Groot PH, Reijngoud DJ, Kuipers F: Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice. Am J Physiol Endocrinol Metab, 2005; 289: E829-E838
70. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, Miller AR, Dai J, Foxworthy P, Gao H, Ryan TP, Jiang XC, Burris TP, Eacho PI, Etgen GJ: Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem, 2003; 278: 1131-1136
71. Commerford SR, Vargas L, Dorfman SE, Mitro N, Rocheford EC, Mak PA, Li X, Kennedy P, Mullarkey TL, Saez E: Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol Endocrinol, 2007; 21: 3002-3012
72. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM: Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature, 2003; 423: 550-555
73. Chakravarty K, Hanson RW: Insulin regulation of phosphoenolpyruvate carboxykinase-c gene transcription: the role of sterol regulatory element-binding protein 1c. Nutr Rev, 2007; 65: S47-S56
74. Ulven SM, Dalen KT, Gustafsson JA, Nebb HI: Tissuespecific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue. J Lipid Res, 2004; 45: 2052-2062
75. Kase ET, Wensaas AJ, Aas V, Hojlund K, Levin K, Thoresen GH, Beck-Nielsen H, Rustan AC, Gaster M: Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes, 2005; 54: 1108-1115
76. Cao G, Bales KR, DeMattos RB, Paul SM: Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeutics. Curr Alzheimer Res, 2007; 4: 179-184
77. Vaya J, Schipper HM: Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem, 2007; 102: 1727-1737
78. Glantzounis GK, Tselepis AD, Tambaki AP, Trikalinos TA, Manataki AD, Galaris DA, Tsimoyiannis EC, Kappas AM: Laparoscopic surgery-induced changes in oxidative stress markers in human plasma. Surgical endoscopy, 2001; 15: 1315-1319
79. Schweinzer C, Kober A, Lang I, Etschmaier K, Scholler M, Kresse A, Sattler W, Panzenboeck U: Processing of endogenous AbetaPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis. J Alzheimers Dis, 2011; 27: 341-360
80. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F: Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A, 2001; 98: 5815-5820
81. Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P: Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci U S A, 2007; 104: 10601-10606
82. Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, de Vente J, Groen AK, Wellington CL, Kuipers F, Mulder M: 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J Biol Chem, 2006; 281: 12799-12808
83. Sun Y, Yao J, Kim TW, Tall AR: Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem, 2003; 278: 27688-27694
84. Ishida E, Hashimoto K, Okada S, Satoh T, Yamada M, Mori M: Crosstalk between thyroid hormone receptor and liver X receptor in the regulation of selective Alzheimer's disease indicator-1 gene expression. PloS one, 2013; 8: e54901
85. Ishida E, Hashimoto K, Okada S, Satoh T, Yamada M, Mori M: Thyroid hormone receptor and liver X receptor competitively up-regulate human selective Alzheimer's disease indicator-1 gene expression at the transcriptional levels. Biochemical and biophysical research communications, 2013; 432: 513-518
86. Jakobsson T, Treuter E, Gustafsson JA, Steffensen KR: Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends in pharmacological sciences, 2012; 33: 394-404
87. Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, Hoffmann A, Subramaniam S, David M, Rosenfeld MG, Glass CK: Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell, 2005; 122: 707-721
88. Castrillo A, Joseph SB, Marathe C, Mangelsdorf DJ, Tontonoz P: Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J Biol Chem, 2003; 278: 10443-10449
89. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P: Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med, 2003; 9: 213-219
90. Fowler AJ, Sheu MY, Schmuth M, Kao J, Fluhr JW, Rhein L, Collins JL, Willson TM, Mangelsdorf DJ, Elias PM, Feingold KR: Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol, 2003; 120: 246-255
91. Hindinger C, Hinton DR, Kirwin SJ, Atkinson RD, Burnett ME, Bergmann CC, Stohlman SA: Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res, 2006; 84: 1225-1234
92. Wang YY, Dahle MK, Agren J, Myhre AE, Reinholt FP, Foster SJ, Collins JL, Thiemermann C, Aasen AO, Wang JE: Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock, 2006; 25: 141-146
93. Chang KC, Shen Q, Oh IG, Jelinsky SA, Jenkins SF, Wang W, Wang Y, LaCava M, Yudt MR, Thompson CC, Freedman LP, Chung JH, Nagpal S: Liver X receptor is a therapeutic target for photoaging and chronological skin aging. Molecular endocrinology (Baltimore, Md), 2008; 22: 2407-2419
94. Annicotte JS, Schoonjans K, Auwerx J: Expression of the liver X receptor alpha and beta in embryonic and adult mice. Anat Rec A Discov Mol Cell Evol Biol, 2004; 277: 312-316
95. Hu MC, Hsu HJ, Guo IC, Chung BC: Function of Cyp11a1 in animal models. Mol Cell Endocrinol, 2004; 215: 95-100
96. Jefcoate C: High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex. J Clin Invest, 2002; 110: 881-890
97. Nilsson M, Stulnig TM, Lin CY, Yeo AL, Nowotny P, Liu ET, Steffensen KR: Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. Mol Endocrinol, 2007; 21: 126-137
98. Jamroz-Wisniewska A, Wojcicka G, Horoszewicz K, Beltowski J: Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications. Postepy Hig Med Dosw (Online), 2007; 61: 760-785
99. Matsumoto S, Hashimoto K, Yamada M, Satoh T, Hirato J, Mori M: Liver X receptor-alpha regulates proopiomelanocortin (POMC) gene transcription in the pituitary. Molecular endocrinology (Baltimore, Md), 2009; 23: 47-60
100. Hashimoto K, Matsumoto S, Ishida E, Miura A, Horiguchi K, Ozawa A, Shibusawa N, Satoh T, Yamada M, Yamada S, Mori M: Liver X receptor-alpha/beta expression ratio is increased in ACTH-secreting pituitary adenomas. Neuroscience letters, 2011; 494: 34-37
101. Lui WY, Mruk D, Lee WM, Cheng CY: Sertoli cell tight junction dynamics: their regulation during spermatogenesis. Biol Reprod, 2003; 68: 1087-1097
102. Volle DH, Mouzat K, Duggavathi R, Siddeek B, Dechelotte P, Sion B, Veyssière G, Benahmed M, Lobaccaro JM: Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility. Mol Endocrinol, 2007; 21: 1014-1027
103. Weinbauer GF, Aslam H, Krishnamurthy H, Brinkworth MH, Einspanier A, Hodges JK: Quantitative analysis of spermatogenesis and apoptosis in the common marmoset (Callithrix jacchus) reveals high rates of spermatogonial turnover and high spermatogenic efficiency. Biol Reprod, 2001; 64: 120-126
104. Kimura M, Itoh N, Takagi S, Sasao T, Takahashi A, Masumori N, Tsukamoto T: Balance of apoptosis and proliferation of germ cells related to spermatogenesis in aged men. J Androl, 2003; 24: 185-191
105. Livera G, Rouiller-Fabre V, Pairault C, Levacher C, Habert R: Regulation and perturbation of testicular functions by vitamin A. Reproduction, 2002; 124: 173-180
106. Biswas NM, Deb C: Testicular degeneration in rats during hypervitaminosis A. Endokrinologie, 1965; 49: 64-69